Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro's price rose sharply from 1 September 2025 because Eli Lilly, the manufacturer, increased its UK list price substantially — the highest-dose pen's list price moved from around £122 to around £330 per four-week supply, as widely reported in August 2025. That increase feeds directly into what private clinics and pharmacies charge. Mounjaro (tirzepatide) is a prescription-only medicine; any legitimate supply requires a clinical assessment by a prescriber, so the price you see should always reflect supervised care, not just the product itself.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The headline fact, reported widely in August 2025 ahead of the change: Eli Lilly raised its UK list price for Mounjaro pens from 1 September 2025. At the highest dose (15mg), the list price increased from roughly £122 to roughly £330 per four-week pen. Lower doses rose proportionally, which means the cost of a full titration course (from the 2.5mg starter pen through to a maintenance dose) became meaningfully more expensive overnight.
Eli Lilly supplies Mounjaro through the licensed UK supply chain, and those list-price changes ripple outward to every pharmacy and clinic that sources the medicine legitimately. There is no workaround: a provider buying through authorised channels cannot sell below the input cost. If you have been trying to understand why the Mounjaro price went up, the cause was a single manufacturer decision rather than individual pharmacies increasing their margins independently.
For more context on how those specific figures break down by dose, our Mounjaro pricing overview sets out current market context, again hedged to reflect that prices can move. The background to the increase is covered in more detail if you want the longer version.
Since the list-price change, reported private market prices for Mounjaro sit roughly between £149 and £375 per month depending on dose and provider. That range is wide, and the gap is not always explained by the medicine alone. Many headline prices exclude the initial consultation fee, the prescription charge, delivery, and any ongoing clinical support between doses.
That matters practically. A titration typically runs over several months; the consultation and prescription fees some providers add at each step can add up. Before comparing quotes, it is worth asking exactly what is (and is not) covered. If you are still wondering why Mounjaro keeps going up in price, a lower monthly figure that excludes clinical aftercare and dose-review support is not necessarily the better deal.
If you are wondering whether the price might come back down, that question has its own page — the short answer is that no reversal has been announced as of summer 2026.
Price is a reasonable thing to scrutinise for most purchases. For a prescription medicine (one that requires clinical assessment, dose titration, and ongoing monitoring) it is genuinely the wrong starting point. The MHRA has warned publicly about counterfeit weight-loss pens sold via social media and unverified online sellers, some of which have contained insulin rather than tirzepatide. Fake pens have resulted in hospitalisations. Sellers offering these medicines without a valid prescription are a red flag, regardless of the price. You can verify any online pharmacy's registration status at the GPhC register before parting with money, it takes about thirty seconds.
The right question is not which provider is cheapest but which provides genuine, clinically supervised treatment from a pharmacy you can verify. That is a different calculation, and the September 2025 price rise makes it more important, not less, because higher prices attract more counterfeiters to fill the gap.
Our guide to finding legitimate Mounjaro supply covers the verification steps in full.
We will say it plainly: we are not the lowest-priced Mounjaro provider, and that is deliberate. Our single transparent price covers the consultation, the prescription, the treatment, and free next-working-day tracked delivery, nothing held back for a follow-up invoice. A named GPhC-registered Independent Prescriber (not software) reads your answers and makes a clinical judgment the same day. That takes time, and it is worth paying for. If you order on a Monday morning (or squeeze in an order before noon on a payday Friday when most people seem to think of it) dispatch goes the same working day, once approved.
Current treatment pricing is shown on our weight-loss treatments page; we do not print per-pen figures in copy because they are tied to dose and clinical pathway. What we can say is that there are no hidden fees, no subscription that renews without a fresh clinical review, and no discount codes, because a discount code on a prescription medicine is not a consumer perk, it is a red flag about how the supply chain is being run.
If you would like to understand more about what Mounjaro is and how it works before starting, our full Mounjaro guide is the place to start. And if you have questions about our clinical team, our prescriber profile sets out who reviews your consultation. For anything else, our team is reachable seven days a week.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.